>>Description of the research protocol "Cortisave"

Corticosteroids in severe alcoholic hepatitis patients with early spontaneous improvement (CORTISAVE)
Phase II study| Status : Ongoing and recruiting

Additional details

Indication (or studied pathology) : Foie
Brugmann identifier : Cortisave
EudraCT identifier : 2016-005136-16
ClinicalTrials.gov identifier : NCT03160651


Involved department : Gastroenterology
Principal investigator : Lasser
Sponsor : Erasme
Contact : Clinical Research Unit

>This protocol was approved by the Erasme ethics committee.